Limbach Holdings (LMB) Tops Q3 EPS by 10c, Beats on Revenue; Offers FY24 Revenue Guidance
Go back to Limbach Holdings (LMB) Tops Q3 EPS by 10c, Beats on Revenue; Offers FY24 Revenue Guidance| Holmes Biopharma, Inc. (NASDAQ: LMB) | Delayed: 50.05 -2.51 (4.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $52.56 | 52 Week High | $0.15 | |||
| Open | $54.00 | 52 Week Low | $0.15 | |||
| Day High | $54.39 | P/E | N/A | |||
| Day Low | $48.89 | EPS | $0.00 | |||
| Volume | 318,475 | |||||
